These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38731909)

  • 1. Plasma Metabolite Profiling in the Search for Early-Stage Biomarkers for Lung Cancer: Some Important Breakthroughs.
    Meynen J; Adriaensens P; Criel M; Louis E; Vanhove K; Thomeer M; Mesotten L; Derveaux E
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the Rewired Metabolism in Lung Cancer Using Quantitative NMR Metabolomics.
    Vanhove K; Derveaux E; Mesotten L; Thomeer M; Criel M; Mariën H; Adriaensens P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis.
    Zhang X; Zhu X; Wang C; Zhang H; Cai Z
    Oncotarget; 2016 Sep; 7(39):63437-63448. PubMed ID: 27566571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer.
    Yang B; Liao GQ; Wen XF; Chen WH; Cheng S; Stolzenburg JU; Ganzer R; Neuhaus J
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):921-933. PubMed ID: 29119730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome.
    Haince JF; Joubert P; Bach H; Ahmed Bux R; Tappia PS; Ramjiawan B
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolite Profiling of Clinical Cancer Biofluid Samples by NMR Spectroscopy.
    Mickiewicz B; Hyndman ME; Vogel HJ
    Methods Mol Biol; 2019; 1928():251-274. PubMed ID: 30725460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of NMR metabolomics to search for human disease biomarkers.
    Gebregiworgis T; Powers R
    Comb Chem High Throughput Screen; 2012 Sep; 15(8):595-610. PubMed ID: 22480238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics.
    Tiziani S; Lopes V; Günther UL
    Neoplasia; 2009 Mar; 11(3):269-76, 4p following 269. PubMed ID: 19242608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer.
    Fahrmann JF; Grapov D; DeFelice BC; Taylor S; Kim K; Kelly K; Wikoff WR; Pass H; Rom WN; Fiehn O; Miyamoto S
    Cancer Biomark; 2016 Mar; 16(4):609-17. PubMed ID: 27002763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Present Situation of Lung Cancer Screening Methods].
    Zhang H; Zhang S
    Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):715-720. PubMed ID: 27760605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plant Metabolomics Using NMR Spectroscopy.
    Selegato DM; Pilon AC; Carnevale Neto F
    Methods Mol Biol; 2019; 2037():345-362. PubMed ID: 31463854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma metabolite profiling reveals potential biomarkers of giant cell tumor of bone by using NMR-based metabolic profiles: A cross-sectional study.
    Wang W; Liu X; Wu J; Kang X; Xie Q; Sheng J; Xu W; Liu D; Zheng W
    Medicine (Baltimore); 2019 Oct; 98(40):e17445. PubMed ID: 31577769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics profile in gastrointestinal cancers: Update and future perspectives.
    Nannini G; Meoni G; Amedei A; Tenori L
    World J Gastroenterol; 2020 May; 26(20):2514-2532. PubMed ID: 32523308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR-Based Prostate Cancer Metabolomics.
    Euceda LR; Andersen MK; Tessem MB; Moestue SA; Grinde MT; Bathen TF
    Methods Mol Biol; 2018; 1786():237-257. PubMed ID: 29786797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature.
    Gyoba J; Shan S; Roa W; Bédard EL
    Int J Mol Sci; 2016 Apr; 17(4):494. PubMed ID: 27043555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis.
    Duarte IF; Rocha CM; Gil AM
    Expert Rev Mol Diagn; 2013 Sep; 13(7):737-48. PubMed ID: 24063400
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.